NCT04083599 2026-04-08
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
Genmab
Phase 1/2 Active not recruiting
Genmab
Verastem, Inc.
Revolution Medicines, Inc.
Bristol-Myers Squibb
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)